Chapter 0: Introduction: 0.1 Future MR developments: vision and realism; 0.2 Magnetic resonance imaging using high power magnetic field gradients; Chapter I: Thorax: I.1 Present status of cardiovascular imaging and quantification; I.2 Blinded assessment of 3D MRA with retrospective respiratory gating for detection of coronary stenoses: A pilot study; I.3 Recurrent coronary artery stenosis: Assessment with 3D MR imaging; I.4 Breath-hold 3D MR coronary angiography (MRCA); I.5 An isolated blood-perfused pig heart preparation to study myocardial perfusion with blood-pool gadolinum-chelate enhanced ultrafast MRI; I.6 Factor analysis of contrast-enhanced first-pass MRI for the detection of coronary artery disease; I.7 Myocardial perfusion reserve from quantitative, ultra-fast MR imaging; I.8 Breath-hold three-dimensional lung perfusion imaging and pulmonary angiography after contrast administration; I.9 Pulmonary embolism detection using contrast-enhanced, breath-hold 3D magnetic resonance angiography; I.10 Oxygen enhanced ventilation MRI of the human lungs; Chapter II: Breast: II.1 Magnetic resonance imaging in breast carcinoma - Initial experience in a third world country; II.2 Integration of MR mammography in the existing diagnostic modalities; II.3 Accuracy of contrast-enhanced dynamic MRI of the breast in patients with suspicious microcalcifications; II.4 Ultrafast dynamic sequential Gadolinium-enhanced MRI scanning of the breast for the screening of women with an enhanced genetic risk; II.5 Response of breast carcinoma to chemotherapy using dynamic MR mammography: Preliminary observations; II.6 The role of half-Fourier 3D dynamic contrast-enhanced MRI of both breasts and azillae in the management of patients with suspected breast cancer; II.7 Fast high resolution imaging of the breast using contrast enhanced 3D-FISP; II.8 Frequency selective imaging of single chemical compounds; II.9 MRI with variable encoding time (VET); Chapter III: Brain: III.1 Vertebro-basilar ischemic stroke: A clinical, MRI and MRA study; III.2 Mapping of local cerebral blood flow by bolus-tracking MRI; III.3 Dynamic echo planar imaging during contrast agent administration with high temporal resolution; III.4 Relative cerebral blood volume mapping for the evaluation of the reserve capacity of the cerebral circulation; III.5 Diffusion weighted imaging of the brain: non-ischemic areas with restricted diffusion; III.6 Anisotropic and isotropic diffusion weighted imaging in ischemic stroke; III.7 The utility of echo-planar diffusion imaging in the evaluation of non-hyperacute cerebral infarction; III.8 Improved pattern recognition in patients with cerebral ischaemia with diffusion weighted magnetic resonance imaging; III.9 Single-shot diffusion weighted imaging of the brain with HASTE; III.10 Echo planar diffusion weighted magnetic resonance imaging in patients with active multiple sclerois; III.11 EPI averaged MT-maps applied to MS lesion inhomogeneity; III.12 MR-dacryocystog
